Mike Kope to speak at Rejuvenation Startup Summit 2022

Mike Kope co-founded SENS Research Foundation in 2009, and was its founding CEO, serving until 2019. He received his J.D. from the University of Michigan in 1990. He has served as the University of Michigan’s Intellectual Property Counsel; Director of Corporate Development for Aviron/MedImmune, Inc.; and as CEO and officer of a number of biotechnology startups.
Mike is CEO of Corporate Affairs at Cyclarity Therapeutics

Dr. Matthew O’Connor was awarded his master’s degree in neuroscience from Northwestern Medical in 1999 and his Ph.D. in Biochemistry from Baylor College of Medicine in 2005. His postdoctoral research includes work at UC Berkeley on muscle stem cells and aging. He is the former VP of Research at SENS Research Foundation where he oversaw a broad swath of research projects spanning many aspects of rejuvenation biotechnology from which he authored many papers and patents.
Matthew is CEO of Scientifc Affairs at Cyclarity Therapeutics

About the Rejuvenation Startup Summit 2022

The Rejuvenation Startup Summit (Berlin, Oct. 14-15, 2022) hosted by the Forever Healthy Foundation, is a vibrant networking event that aims to accelerate the development of the rejuvenation biotech industry.

Rejuvenation/Longevity biotech is a new, emerging field of medicine. It aims to prevent and reverse diseases of aging by addressing their common root cause, the aging process itself. Rejuvenation therapies aim to reverse or repair age-related cellular changes such as molecular waste, calcification, tissue stiffening, loss of stem cell function, genetic alterations, and impaired energy production.

The Rejuvenation Summit brings together startups, members of the longevity venture capital / investor ecosystem, and researchers interested in founding or joining a startup – all aiming to create therapies to vastly extend the healthy human lifespan.

Further information can be found at www.forever-healthy.org/summit/

About Cyclarity Therapeutics

Cyclarity Therapeutics, Inc. develops easy-to-use drugs that prevent common age-related conditions such as atherosclerosis, heart-attack and stroke by addressing the root cause – a build-up of arterial plaque. The company’s technology removes arterial plaque by clearing the non-degradable cholesterol that accumulates within cells in the arterial walls. Cyclarity’s long-term goal is to deliver a simple and affordable preventive therapy for the world.

For more information, please visit www.cyclaritytx.com/

For free media & press passes, please contact:

Frank Schueler, COO Forever Healthy Foundation
fs@forever-healthy.org